Cartherics Pty ltd products

This technology involves induced pluripotential stem cell (iPSC) derived NK cells (and, potentially, other types of immune cells). iPSCs have unlimited capacity for self-renewal.

This technology arms the patient’s own T cells with CARs, which enable them to “seek and destroy” cancer cells.